CDC Halts Hazardous Biomaterial Transfers

Following recent high-profile safety lapses in government labs, the US Centers for Disease Control and Prevention has placed a moratorium on movement of biological materials from BSL-3 and BSL-4 facilities.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

CDCThe US Centers for Disease Control and Prevention (CDC) is investigating yet another safety incident after the agency’s influenza lab personnel reported the inadvertent contamination of an avian influenza virus sample shipped to a US Department of Agriculture facility (USDA) with the highly pathogenic H5N1. The incident, announced today (July 11), is the third safety breach within the last month, with a CDC lab seeing the release of—and potential exposure of dozens of employees to—anthrax bacteria in mid-June, followed by the discovery of six forgotten vials of smallpox virus in US Food and Drug Administration (FDA) storage this week.

Coinciding with the release of a report reviewing the anthrax incident, the CDC has placed a moratorium on movement of biological materials from biosafety level (BSL)-3 and BSL-4 facilities. Additionally, the agency announced Michael Bell, deputy director of the Division of Healthcare Quality Promotion, as its new director of lab safety, reporting directly to CDC Director Thomas Frieden.

During a press briefing today, Frieden said six weeks passed before the H5N1 contamination incident was reported to agency officials. “That kind of delay is very troubling,” Frieden said, noting that no one was exposed to the flu virus, which has since been destroyed.

Tests on the samples found in FDA storage revealed that two of the six contained viable smallpox virus, Frieden said today.

“These events ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo